A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities
Vaccines · 25.04.2023 · 11 (5) · 895
DOI: 10.3390/vaccines11050895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 25.04.2023. Verfasst von Laila N Khorasani und 9 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association of University Centers on Disabilities, Centers for Disease Control, Regional Hub Mini-Grant.
Abstract (Originalsprache)
Vaccine hesitancy is a major barrier to vaccination, hindering the success of vaccine efforts and thereby increasing public health risk to viral diseases, including COVID-19. Neurodivergent (ND) individuals, including individuals with an intellectual and/or developmental disability, have demonstrated a heightened risk of hospitalization and death due to COVID-19, highlighting the need for further research specifically on ND communities. We conducted a qualitative analysis using in-depth interviews with medical professionals, non-medical health professionals and communicators, and ND individuals or their caregivers. Using a thematic coding analysis methodology, trained coders identified major themes according to 24 distinct codes spanning across the categories of (1) barriers to vaccination; (2) facilitators to vaccination; and (3) suggestions for improving vaccine confidence. Qualitative findings identify misinformation, perception of vaccine risk, sensory sensitivities, and structural hardship as the most significant barriers to COVID-19 vaccination. We highlight the importance of accommodations to vaccination for the ND community alongside coordinated efforts by healthcare leaders to direct their communities to accurate sources of medical information. This work will inform the direction of future research on vaccine hesitancy, and the development of programs specific to the ND community’s access to vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
- Graduate School of Education, University of California, Riverside, CA 92521, USA.
ORCID-Profile: Asal Bastani, Tammy Shen, Gurlovellen Kaur, Nilpa D Shah, Julie Grassian
Förderung
- Association of University Centers on Disabilities
- Centers for Disease Control, Regional Hub Mini-Grant
Zitieren
APA
Khorasani, L. N., Bastani, A., Shen, T., Kaur, G., Shah, N. D., Juarez, L., Heyman, M., Grassian, J., Cho, A. C., & Hotez, E. (2023). A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines, 11(5), 895. https://doi.org/10.3390/vaccines11050895
Vancouver
Khorasani LN, Bastani A, Shen T, Kaur G, Shah ND, Juarez L, et al. A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities. Vaccines. 2023;11(5):895. doi:10.3390/vaccines11050895
BibTeX
@article{Khorasani2023,
author = {Khorasani, Laila N and Bastani, Asal and Shen, Tammy and Kaur, Gurlovellen and Shah, Nilpa D and Juarez, Lucia and Heyman, Michelle and Grassian, Julie and Cho, An-Chuen and Hotez, Emily},
title = {A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities},
journal = {Vaccines},
year = {2023},
volume = {11},
number = {5},
pages = {895},
doi = {10.3390/vaccines11050895}
}
EUVIMED